Prostate Cancer: Medical Treatments
Commons · Question 109128 · Tabled 28 Jan 2026 · Department of Health and Social Care · Official record
Answered 3 Feb 2026
Question
Asked by Wendy Morton
To ask the Secretary of State for Health and Social Care, with reference to HCWS1248, what assessment has been made of existing regional variation in access to prostate cancer treatments and what steps are being taken to prevent disparities in uptake betw
Answer
Answered by Zubir Ahmed, 3 Feb 2026
Approximately 2,000 men diagnosed in the last three months with non‑metastatic prostate cancer will now be able to receive abiraterone where it is of clinical benefit, alongside prednisolone. An additional 7,000 men are expected to be diagnosed with prost...